索引于
  • 打开 J 门
  • Genamics 期刊搜索
  • 学术钥匙
  • 期刊目录
  • 全球影响因子 (GIF)
  • 中国知网(CNKI)
  • 乌尔里希的期刊目录
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-WorldCat
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • 谷歌学术
分享此页面
期刊传单
Flyer image

抽象的

Nevirapine Co-crystals Activity on Humans

Jelabel Hak

Nevirapine (NV) is a non-nucleoside switch transcriptase inhibits or used in blend with other antiretroviral drugs for the treatment of Human Immunodeficiency Virus (HIV) contaminations. NV directly inhibits switch transcriptase movement consequently stifling DNA replication of the HIV infection and is known to forestall HIV transmission from mother to baby. A solitary portion of NV directed to the mother at the beginning of work and to the infant inside 72 hours of delivery almost divided the pace of HIV transmission. Since NV is given only once to the mother and child it is moderately modest and simple to administer [1-3]. NV is essentially insoluble in water with a fluid solvency of 0.1 mg/ml-1 (pH 7, Temp. 37°C). As per the Biopharmaceutical Classification Index, NV is a Class II sedate for example it has a high permeability and a low solvency . The low pace of disintegration of NV is assumed to be the rate-restricting advance for assimilation of the medication [4]. Co-gems, a translucent structure, containing at least two different components in an unmistakable stoichiometric proportion was researched to enhance the solvency, bioavailability and the disintegration pace of NV.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证